Menu

Distantly Related Conifers Share a Surprising Number of Cold-Tolerance Genes

Spruce and pine and have relied on similar genetic toolkits for climate adaptation despite millions of years of evolution.

Dec 1, 2016
Ben Andrew Henry

Snowed In: Spruce and pine parted evolutionary ways long ago, but their cold-adaptation genes are surprisingly similar. SALLY AITKEN

EDITOR'S CHOICE IN EVOLUTION

The Paper
S. Yeaman et al., “Convergent local adaptation to climate in distantly related conifers,” Science, 353:1431-33, 2016.

Family Trees
Related species sometimes adapt to similar environments with mutations in the same genes. But convergent evolution is usually observed in species that recently diverged or in traits that involve only a few genes and therefore may have fewer possible evolutionary paths. New research from the snowy North tells a different story.

Winter Specialists
Interior spruces (Picea glauca and P. engelmannii) and lodgepole pine (Pinus contorta) each have hundreds of genes that contribute to one outcome: surviving the brutal winters of Canada and the northern U.S. “You would think that there would be many ways to get the same phenotype” with so many genes involved, says Sally Aitken, a population geneticist at the University of British Columbia. And yet, the two conifer groups share 10 percent to 18 percent of their cold-adaptation genes, Aitken and her colleagues report in a recent study.

Cold Convergence
These species diverged when the Earth’s climate was warmer, around 140 million years ago—leaving plenty of time to evolve unique genes. Although different variants of those genes arose in each species, evolution appears to have put them to use in the same way. The study suggests evolution “is repeatable even though these trees diverged so, so long ago,” says Patrik Nosil, an evolutionary biologist at the University of Sheffield in the U.K.

Frozen in Time
One possible explanation, Aitken says, is that the strong selective pressure of the climate constrained the emergence of new genes, forcing these species to rely on variants of old genes.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.